What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Pathology, Lymphoma, Cancer research, Internal medicine and Immunophenotyping.
Pathology is frequently linked to Leukemia in his study.
He interconnects Biopsy and Germinal center in the investigation of issues within Lymphoma.
His research on Cancer research also deals with topics like
- Cell cycle which connect with Programmed cell death,
- Kinase, which have a strong connection to Immunohistochemistry.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery, Oncology and Immunology.
His Immunophenotyping study combines topics from a wide range of disciplines, such as Waldenstrom macroglobulinemia, Lymphoplasmacytic Lymphoma, Gene rearrangement, CD33 and Chromosome abnormality.
His most cited work include:
- The Heidelberg classification of renal cell tumours (1157 citations)
- High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine (465 citations)
- MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program (423 citations)
What are the main themes of his work throughout his whole career to date?
L. Jeffrey Medeiros mainly investigates Pathology, Lymphoma, Internal medicine, Cancer research and Oncology.
L. Jeffrey Medeiros has included themes like Leukemia, Myeloid leukemia and Immunophenotyping in his Pathology study.
His Lymphoma study is associated with Immunology.
L. Jeffrey Medeiros has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His study in Cancer research is interdisciplinary in nature, drawing from both Chronic lymphocytic leukemia and B cell.
His Diffuse large B-cell lymphoma study combines topics from a wide range of disciplines, such as CHOP and Germinal center.
He most often published in these fields:
- Pathology (46.01%)
- Lymphoma (32.46%)
- Internal medicine (26.21%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (26.21%)
- Cancer research (23.09%)
- Pathology (46.01%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Cancer research, Pathology, Lymphoma and Oncology.
While the research belongs to areas of Internal medicine, L. Jeffrey Medeiros spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Myelofibrosis and Stage.
The Cancer research study combines topics in areas such as Anaplastic lymphoma kinase and Immunotherapy.
His Pathology study frequently draws connections to other fields, such as Gene rearrangement.
His Lymphoma research incorporates themes from Immunophenotyping and B cell.
L. Jeffrey Medeiros interconnects Fluorescence in situ hybridization, Radiation therapy and Philadelphia chromosome in the investigation of issues within Oncology.
Between 2017 and 2021, his most popular works were:
- Diffuse large B-cell lymphoma. (148 citations)
- Genetic subtyping of breast implant–associated anaplastic large cell lymphoma (48 citations)
- Breast implant-associated anaplastic large cell lymphoma: a review. (39 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
L. Jeffrey Medeiros mostly deals with Lymphoma, Internal medicine, Pathology, Cancer research and Oncology.
His studies in Lymphoma integrate themes in fields like Large cell and B cell.
His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
He regularly links together related areas like Immunophenotyping in his Pathology studies.
His Cancer research research integrates issues from Protein kinase B, Pathogenesis, Ibrutinib, Prognostic factor and Immunotherapy.
He has included themes like Cytarabine, Myeloid leukemia, Complex Karyotype and Germinal center in his Oncology study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
